Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.47.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.7.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.42.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
KP.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.48.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.32.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used